Author:
Xu Stanley,Huang Runxin,Sy Lina S.,Glenn Sungching C.,Ryan Denison S.,Morrissette Kerresa,Shay David K.,Vazquez-Benitez Gabriela,Glanz Jason M.,Klein Nicola P.,McClure David,Liles Elizabeth G.,Weintraub Eric S.,Tseng Hung-Fu,Qian Lei
Publisher
Centers for Disease Control MMWR Office
Subject
Health Information Management,Health, Toxicology and Mutagenesis,General Medicine,Health (social science),Epidemiology
Reference10 articles.
1. Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine.;Polack;N Engl J Med,2020
2. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine.;Baden;N Engl J Med,2021
3. Food and Drug Administration. Janssen COVID-19 vaccine Emergency Use Authorization letter. Silver Spring, MD: US Department of Health and Human Services, Food and Drug Administration; 2021. https://www.fda.gov/media/146303/download
4. Evidence-based strategies for clinical organizations to address COVID-19 vaccine hesitancy.;Finney Rutten;Mayo Clin Proc,2021
5. Adverse events following mRNA SARS-CoV-2 vaccination among U.S. nursing home residents.;Bardenheier;Vaccine,2021
Cited by
84 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献